Davide Malavasi
Chief Tech/Sci/R&D Officer presso COSMO PHARMACEUTICALS N.V.
Provenienza dei contatti di primo grado di Davide Malavasi
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 29 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Davide Malavasi tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| AGNICO EAGLE MINES LIMITED | Precious Metals | Public Communications Contact | |
Osteotech, Inc.
 Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Medical Specialties | Corporate Officer/Principal | |
| UBS | Investment Managers | Corporate Officer/Principal | |
Cumberland Resources Ltd.
 Cumberland Resources Ltd. Precious MetalsNon-Energy Minerals Cumberland Resources Ltd. engages in the exploration and development of mineral properties in Canada. The firm has interests in two gold projects located in Nunavut Territory, Canada. The company was founded on December 4, 1979 and is headquartered in Vancouver, Canada. | Precious Metals | Public Communications Contact | |
Santarus, Inc.
 Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Sales & Marketing Director/Board Member | |
| PRIVATE EQUITY HOLDING AG | Investment Managers | Director/Board Member | |
| PAION AG | Pharmaceuticals: Major | Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member | |
20 Minuten-Holding AG
 20 Minuten-Holding AG Publishing: NewspapersConsumer Services Part of Schibsted ASA, 20 Minuten-Holding AG is a holding group with interests in publishing. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans Christoph Tanner. Sverre Christian Munck has been the CEO of the company since 2002. | Publishing: Newspapers | Founder | |
Poli Industria Chimica
 Poli Industria Chimica Pharmaceuticals: MajorHealth Technology Poli Industria Chimica specializes in the manufacture and development of pharmaceutical drugs and ingredients. They offer products used in pharmacology, chemical and botanical preparations and applications. The company was founded in 1946 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Ernst Mueller Moehl
 Ernst Mueller Moehl Investment Banks/BrokersFinance Ernst Mueller Moehl provides investment services. The private company is based in Zurich, Switzerland. and has subsidiaries in Switzerland. | Investment Banks/Brokers | Corporate Officer/Principal | |
Ospedale San Raffaele Srl
 Ospedale San Raffaele Srl Hospital/Nursing ManagementHealth Services Ospedale San Raffaele Srl is engaged in hospital business. The company is headquartered in Milan, Italy. | Hospital/Nursing Management | Corporate Officer/Principal | |
20 Minuten AG
 20 Minuten AG Publishing: NewspapersConsumer Services 20 Minuten AG publishes newspapers and provides online information services. It also provides French-language edition 20 minutes for the French-speaking agglomerations of Geneva and Lausanne. In France, the identically named 20 minutes editions are published by Schibsted and Ouest-France. The company is headquartered in Zurich, Switzerland. | Publishing: Newspapers | Founder | |
| Alma Mater Studiorum - Università di Bologna | College/University | Undergraduate Degree Undergraduate Degree | |
| University College Dublin | College/University | Undergraduate Degree Graduate Degree | |
| University of St. Gallen | College/University | Doctorate Degree | |
| DKSH HOLDING AG | Medical Distributors | Director/Board Member | |
| Sapienza University of Rome | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
| University of Bocconi | College/University | Undergraduate Degree | |
| University of Pavia | College/University | Graduate Degree | |
| University of Milan | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
UBS South Africa (Pty) Ltd.
 UBS South Africa (Pty) Ltd. Investment Banks/BrokersFinance UBS South Africa (Pty) Ltd. (UBSSA) is the broker subsidiary of UBS AG, which is ultimately held by UBS Group AG (NYSE: UBS). The firm is headquartered in Johannesburg. UBSSA provides brokerage services to private, institutional and corporate clients. | Investment Banks/Brokers | Corporate Officer/Principal | |
| CASSIOPEA S.P.A. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Cosmo Holding SpA manufactures and markets pharmaceutical products. It develops technologies in the sector of modified drug release with oral, topical, and transmucosal applications. The company was founded in 1996 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Canadian Investor Relations Institute
 Canadian Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services The Canadian Investor Relations Institute (CIRI) is a professional organization that aims to enhance the credibility and competency of the investor relations profession. CIRI has four chapters located in different regions. The organization also provides insights on ESG processes and reporting for issuers at various stages in their ESG journey. The non-profit company is based in Oakville, ON, Canada. CIRI provides resources, professional development, networking opportunities, and advocacy to support the IR community. The organization has over 500 members, with most responsible for IR at publicly-traded companies. Visible Alpha is a sponsor of CIRI that enhances the investment research process. CIRI publishes IR Directions, a magazine that explores current and emerging practices of board reporting and engagement. Nathalie Megann has been the CEO of the Canadian company since 2004. | Miscellaneous Commercial Services | Director/Board Member | |
Fondazione San Raffaele del Monte Tabor-Milano
 Fondazione San Raffaele del Monte Tabor-Milano Hospital/Nursing ManagementHealth Services Fondazione San Raffaele del Monte Tabor-Milano provides medical care and clinical support to patients. They carry out biomedical research and clinical activities. The company is based in Milan, Italy. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
| University of Turin | College/University | Doctorate Degree | |
| Cosmo Bioscience SpA | Director/Board Member Chairman | ||
| Cosmo Bioscience, Inc. | Director/Board Member | ||
Società Prodotti Antibiotici SpA
 Società Prodotti Antibiotici SpA Pharmaceuticals: MajorHealth Technology Società Prodotti Antibiotici SpA is a pharmaceutical firm. The company was founded in 1947 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Joimax GmbH focuses on innovative technologies, systems and methods for endoscopic minimally invasive spinal surgery. Its products include endoscopic systems, spinal implants, pain therapy systems, VBA management programs, endoscopic devices and user protection. The company was founded by Wolfgang Ries in November 2001 and is headquartered in Karlsruhe, Germany. | Medical Specialties | Director/Board Member | |
UBS Australia Pty Ltd.
 UBS Australia Pty Ltd. Investment ManagersFinance Part of UBS Group AG, UBS Australia Pty Ltd. is an Australian company that provides wealth management, asset management and investment banking services. The private company is based in Sydney, Australia. The CEO of the company is Matthew Grounds. | Investment Managers | Corporate Officer/Principal | |
| Academia Europaea Ltd | Corporate Officer/Principal | ||
Qvanteq AG
 Qvanteq AG BiotechnologyHealth Technology Qvanteq AG develops novel bioactive stents to address and overcome the clinical adverse. Its products include technology, intracranial stents, Qstent Periphry, and Qstent Coronary. The company was founded in 2009 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member | |
| San Raffaele-Telethon Institute for Gene Therapy | Director/Board Member | ||
| Stiftung Für Angewandte Krebsforschung | Chairman | ||
Wergen & Partner Vermögensverwaltungs AG
 Wergen & Partner Vermögensverwaltungs AG Financial ConglomeratesFinance Wergen & Partner Vermögensverwaltungs AG provides asset management services to private and institutional clients. The company was founded by Manfred Wergen and is headquartered in Wilen bei Wollerau, Switzerland. | Financial Conglomerates | Chairman | |
FARa Holz AG
 FARa Holz AG Forest ProductsNon-Energy Minerals FARa Holz AG is a timber trading company based in Zug, Switzerland. FARa Holz is located at Sagistrasse 10, 6300 Zug, Switzerland. The Swiss company specializes in providing wood materials for construction, including wooden structures, cover parking chains, and laminated wood. The private company also offers wood declaration services, advice, and technology. FARa Holz has a team of specialists with many years of experience in the timber trade, and they cater to wooden builders, carpenters, floor layers, roofers, and other woodworking companies. The company also provides advice to architects and construction planners. The company's mission is to have the most satisfied customers in their performance area and the most motivated employees. | Forest Products | Director/Board Member | |
Bank Julius Bär & Co. Ltd. /CH/
 Bank Julius Bär & Co. Ltd. /CH/ Major BanksFinance Part of Julius Bär Gruppe AG, Bank Julius Bär & Co. Ltd. is a banking company based in Zurich, Switzerland. The Swiss company provides banking services. Philipp Rickenbacher has been the CEO of the private company since 2009. | Major Banks | Director of Finance/CFO | |
Wyss Zurich
 Wyss Zurich Investment ManagersFinance Wyss Zurich is an accelerator/incubator with headquarters in Zurich, Switzerland. The firm was founded in 2015. | Investment Managers | Director/Board Member | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Lifematrix Technologies AG
 Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Lifematrix Technologies AG develops human cell-derived and off-the-shelf available tissue-engineered implants. The company is based in Zurich, Switzerland. The Swiss company was founded by René Stenger and Robin Müller. The CEO is Maximilian Emmert. | Miscellaneous Commercial Services | Director/Board Member | |
Giuliani SpA
 Giuliani SpA Pharmaceuticals: MajorHealth Technology Giuliani SpA manufactures and distributes health and beauty products. It develops products and has contributed to promoting pharmaceutical awareness among the public, becoming one of Italy's pharmaceutical manufacturers. The company was founded in 1889 by Germano Giuliani and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
| Italia | 20 |
| Svizzera | 16 |
| Stati Uniti | 5 |
| Germania | 5 |
| Canada | 4 |
Settori
| Health Technology | 15 |
| Consumer Services | 11 |
| Finance | 10 |
| Non-Energy Minerals | 4 |
| Commercial Services | 4 |
Posizioni
| Director/Board Member | 74 |
| Corporate Officer/Principal | 58 |
| Chief Tech/Sci/R&D Officer | 21 |
| Chairman | 20 |
| Undergraduate Degree | 14 |
Contatti più connessi
- Borsa valori
- Insiders
- Davide Malavasi
- Connessioni Società
